Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Mol Cancer Ther. 2015 Feb 5;14(4):899–908. doi: 10.1158/1535-7163.MCT-14-0775

Figure 2.

Figure 2

Effect of MN58b on ChoK activity in tumor cells. Autoradiography of TLC-separated 14C-choline containing metabolites (A) allows for the quantification of 14C-PC and demonstrates a dose-dependent reduction of choline phosphorylation in response to MN58b treatment. The graph (B) shows a dose dependent reduction of ChoK activity in the F98, 9L and 9L-EGFRviii cell lines. Error bars represent ± SEM of 3 separate experiments.